SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000926617-21-000047
Filing Date
2021-05-10
Accepted
2021-05-07 19:36:49
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A awh-20210508xdefa14a.htm DEFA14A 38585
2 GRAPHIC awh-20210508xdefa14ag001.jpg GRAPHIC 143590
3 GRAPHIC awh-20210508xdefa14ag002.jpg GRAPHIC 148486
  Complete submission text file 0000926617-21-000047.txt   442473
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Filer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-34810 | Film No.: 21904798
SIC: 2835 In Vitro & In Vivo Diagnostic Substances